66 related articles for article (PubMed ID: 11715452)
1. [Different expressions of cyclins and cyclin dependent kinase inhibitor P27 in vascular smooth muscle cells and cardiac myocytes caused by angiotensin II and PDGF stimulation].
Xu D; Yuan Y; Liu Y
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):657-60. PubMed ID: 11715452
[TBL] [Abstract][Full Text] [Related]
2. [The role of cyclin-dependent kinase inhibitors in hyperplasia and hypertrophy of vascular smooth muscle cells].
Xu D; Wang M; Liu Y
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):680-3. PubMed ID: 11798949
[TBL] [Abstract][Full Text] [Related]
3. [Expression of cyclin dependent kinase inhibitor p27 during proliferation in vascular smooth muscle cell].
Yuan Y; Xu DL; Liu YL; Jia MY
Sheng Li Xue Bao; 1999 Jun; 51(3):285-90. PubMed ID: 11498990
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms.
Servant MJ; Coulombe P; Turgeon B; Meloche S
J Cell Biol; 2000 Feb; 148(3):543-56. PubMed ID: 10662779
[TBL] [Abstract][Full Text] [Related]
5. Short-term stimulation of vascular smooth muscle cells with platelet-derived growth factor (PDGF)-BB and angiotensin II induces.
Gouni-Berthold I; Berthold HK; Seewald S; Seul C; Ko Y; Vetter H; Sachinidis A
Scand J Clin Lab Invest; 2000 Dec; 60(8):723-31. PubMed ID: 11218155
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II and PDGF-BB stimulate beta(1)-integrin-mediated adhesion and spreading in human VSMCs.
Kappert K; Schmidt G; Doerr G; Wollert-Wulf B; Fleck E; Graf K
Hypertension; 2000 Jan; 35(1 Pt 2):255-61. PubMed ID: 10642307
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
[TBL] [Abstract][Full Text] [Related]
8. PDGF-BB-induced DNA synthesis is delayed by angiotensin II in vascular smooth muscle cells.
Dahlfors G; Chen Y; Wasteson M; Arnqvist HJ
Am J Physiol; 1998 May; 274(5):H1742-8. PubMed ID: 9612386
[TBL] [Abstract][Full Text] [Related]
9. A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.
Braun-Dullaeus RC; Mann MJ; Ziegler A; von der Leyen HE; Dzau VJ
J Clin Invest; 1999 Sep; 104(6):815-23. PubMed ID: 10491417
[TBL] [Abstract][Full Text] [Related]
10. PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells.
Sakakibara K; Kubota K; Worku B; Ryer EJ; Miller JP; Koff A; Kent KC; Liu B
J Biol Chem; 2005 Jul; 280(27):25470-7. PubMed ID: 15894805
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
Pukac L; Huangpu J; Karnovsky MJ
Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1.
Ha JM; Yun SJ; Kim YW; Jin SY; Lee HS; Song SH; Shin HK; Bae SS
Biochem Biophys Res Commun; 2015 Aug; 464(1):57-62. PubMed ID: 26032503
[TBL] [Abstract][Full Text] [Related]
13. Gleditsia sinensis thorn extract inhibits the proliferation and migration of PDGF‑induced vascular smooth muscle cells.
Park SS; Kim WJ; Moon SK
Mol Med Rep; 2014 Oct; 10(4):2031-8. PubMed ID: 25069874
[TBL] [Abstract][Full Text] [Related]
14. [Regulation of cyclin-dependent kinase inhibitors by mitogen-activated protein kinase in angiotensin II-stimulated vascular smooth muscle cell hypertrophy].
Liu Y; Xu DL; Wang MH; Ouyang P; Lai WY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):114-6. PubMed ID: 12390801
[TBL] [Abstract][Full Text] [Related]
15. [Effects of human tissue kallikrein gene delivery on the proliferation of vascular smooth muscle cells].
Zhu PL; Yu HZ; Xie LD; Ruan JM; Xu CS; Li TY
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Aug; 38(8):739-44. PubMed ID: 21055144
[TBL] [Abstract][Full Text] [Related]
16. Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor.
Witzenbichler B; Kureishi Y; Luo Z; Le Roux A; Branellec D; Walsh K
J Clin Invest; 1999 Nov; 104(10):1469-80. PubMed ID: 10562309
[TBL] [Abstract][Full Text] [Related]
17. A novel roscovitine derivative potently induces G1-phase arrest in platelet-derived growth factor-BB-activated vascular smooth muscle cells.
Sroka IM; Heiss EH; Havlicek L; Totzke F; Aristei Y; Pechan P; Kubbutat MH; Strnad M; Dirsch VM
Mol Pharmacol; 2010 Feb; 77(2):255-61. PubMed ID: 19903826
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells.
Cospedal R; Lobo M; Zachary I
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):407-14. PubMed ID: 10455028
[TBL] [Abstract][Full Text] [Related]
19. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells.
Liang KW; Yin SC; Ting CT; Lin SJ; Hsueh CM; Chen CY; Hsu SL
Eur J Pharmacol; 2008 Aug; 590(1-3):343-54. PubMed ID: 18590725
[TBL] [Abstract][Full Text] [Related]
20. NOS gene transfer inhibits expression of cell cycle regulatory molecules in vascular smooth muscle cells.
Sharma RV; Tan E; Fang S; Gurjar MV; Bhalla RC
Am J Physiol; 1999 May; 276(5):H1450-9. PubMed ID: 10330227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
